Interested mainly in nanomedicines for cancer detection and therapy, Petras Juzėnas carries out research in collaboration with Norway's top medical and research authorities.Petras Juzėnas received his university degree in Physics and Biophysics in 1995 at Vilnius University, Vilnius, Lithuania, and got his PhD degree in 2002 from the University of Oslo and Norwegian Radium Hospital, Oslo, Norway, where he currently works as a scientist at the Institute for Cancer Research.
He is interested in the research and development of nanoparticles for cancer therapy. In 2006-2007 he collaborated with the pharmaceutical company Epitarget AS on sonosensitive liposomes for enhancement of chemotherapy. Since 2008 his laboratory is investigating responsiveness of nanoparticles to radiation for photodynamic and radiation therapies of cancer.
His recent key projects include the Uptake and toxicity of quantum dots in cancer cells (2007-2011, supported by the Research Council of Norway), and
Combination therapy with bortezomib, nanoparticles and radiation against cancer and neurodegenerative diseases (2007-2011, supported by the South-Eastern Norway Regional Health Authority).
Petras Juzėnas is coauthor of more than 60 scientific articles and 7 book chapters. He serves as editor for Reviews in Nanoscience and Nanotechnology, Journal of Biomedical Nanotechnology and Medicina (Kaunas). He is a member of the European Technology Platform on Nanomedicine, the Norwegian NanoMedicine Network, the European Platform for Photodynamic Medicine, the European Society for Photobiology, the American Society for Photobiology, and the Norwegian Society for Photobiology and Photomedicine.